BR0015082A - Derivado de ácido hidroxâmico como inibidor da formação de cd 23 humano solúvel - Google Patents
Derivado de ácido hidroxâmico como inibidor da formação de cd 23 humano solúvelInfo
- Publication number
- BR0015082A BR0015082A BR0015082-7A BR0015082A BR0015082A BR 0015082 A BR0015082 A BR 0015082A BR 0015082 A BR0015082 A BR 0015082A BR 0015082 A BR0015082 A BR 0015082A
- Authority
- BR
- Brazil
- Prior art keywords
- inhibitor
- formation
- acid derivative
- hydroxamic acid
- soluble human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
"DERIVADO DE áCIDO HIDROXâMICO COMO INIBIDOR DA FORMAçãO DE CD 23 HUMANO SOLúVEL". A presente invenção refere-se a um composto de fórmula (I), em que: R é isopropila, n é 0, R^ 1^ é naftil metila, R^ 2^ é t-butila, e R^ 3^ é metila, sendo útil no tratamento de distúrbios mediados por s-CD23.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9925470.8A GB9925470D0 (en) | 1999-10-27 | 1999-10-27 | Novel compounds |
| PCT/EP2000/010649 WO2001030747A1 (en) | 1999-10-27 | 2000-10-25 | Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0015082A true BR0015082A (pt) | 2003-04-15 |
Family
ID=10863507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0015082-7A BR0015082A (pt) | 1999-10-27 | 2000-10-25 | Derivado de ácido hidroxâmico como inibidor da formação de cd 23 humano solúvel |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US6673965B1 (pt) |
| EP (1) | EP1224164B1 (pt) |
| JP (1) | JP3922431B2 (pt) |
| KR (1) | KR20020044578A (pt) |
| CN (1) | CN1182107C (pt) |
| AR (1) | AR026244A1 (pt) |
| AT (1) | ATE284382T1 (pt) |
| AU (1) | AU766072B2 (pt) |
| BR (1) | BR0015082A (pt) |
| CA (1) | CA2389319A1 (pt) |
| CO (1) | CO5261576A1 (pt) |
| CZ (1) | CZ20021424A3 (pt) |
| DE (1) | DE60016622T2 (pt) |
| DK (1) | DK1224164T3 (pt) |
| ES (1) | ES2233474T3 (pt) |
| GB (1) | GB9925470D0 (pt) |
| GC (1) | GC0000142A (pt) |
| HK (1) | HK1049146A1 (pt) |
| HU (1) | HUP0203270A3 (pt) |
| IL (1) | IL149364A0 (pt) |
| MX (1) | MXPA02004228A (pt) |
| MY (1) | MY133601A (pt) |
| NO (1) | NO20021965L (pt) |
| NZ (1) | NZ518566A (pt) |
| PE (1) | PE20010898A1 (pt) |
| PL (1) | PL356524A1 (pt) |
| PT (1) | PT1224164E (pt) |
| SI (1) | SI1224164T1 (pt) |
| TW (1) | TW561141B (pt) |
| UY (1) | UY26416A1 (pt) |
| WO (1) | WO2001030747A1 (pt) |
| ZA (1) | ZA200203255B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2735929C (en) * | 2008-09-19 | 2013-12-17 | Pfizer Inc. | Hydroxamic acid derivatives useful as antibacterial agents |
| JP5836968B2 (ja) | 2009-12-01 | 2015-12-24 | ボストン メディカル センター コーポレーション | ＩｇＥ媒介性疾患の処置方法 |
| EP2512474B1 (en) | 2009-12-16 | 2014-11-05 | Pfizer Inc | N-linked hydroxamic acid derivatives useful as antibacterial agents |
| ES2626457T3 (es) | 2011-03-07 | 2017-07-25 | Pfizer Inc. | Derivados de fluoro-piridinona útiles como agentes antibacterianos |
| KR20130140868A (ko) | 2011-04-08 | 2013-12-24 | 화이자 인코포레이티드 | 항세균제로서 유용한 이속사졸 유도체 |
| SG193458A1 (en) | 2011-04-08 | 2013-10-30 | Pfizer | Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
| EP2525213A1 (en) * | 2011-05-16 | 2012-11-21 | Renishaw plc | Spectroscopic apparatus and methods for determining components present in a sample |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9513331D0 (en) | 1995-06-30 | 1995-09-06 | British Biotech Pharm | Matrix metalloproteinase inhibitors |
| GB9813451D0 (en) * | 1998-06-22 | 1998-08-19 | Smithkline Beecham Plc | Novel compounds |
-
1999
- 1999-10-27 GB GBGB9925470.8A patent/GB9925470D0/en not_active Ceased
-
2000
- 2000-10-25 US US10/111,209 patent/US6673965B1/en not_active Expired - Fee Related
- 2000-10-25 MY MYPI20005012A patent/MY133601A/en unknown
- 2000-10-25 AT AT00975954T patent/ATE284382T1/de not_active IP Right Cessation
- 2000-10-25 PT PT00975954T patent/PT1224164E/pt unknown
- 2000-10-25 AU AU13895/01A patent/AU766072B2/en not_active Ceased
- 2000-10-25 CZ CZ20021424A patent/CZ20021424A3/cs unknown
- 2000-10-25 DE DE60016622T patent/DE60016622T2/de not_active Expired - Lifetime
- 2000-10-25 EP EP00975954A patent/EP1224164B1/en not_active Expired - Lifetime
- 2000-10-25 JP JP2001533102A patent/JP3922431B2/ja not_active Expired - Fee Related
- 2000-10-25 CA CA002389319A patent/CA2389319A1/en not_active Abandoned
- 2000-10-25 UY UY26416A patent/UY26416A1/es not_active Application Discontinuation
- 2000-10-25 WO PCT/EP2000/010649 patent/WO2001030747A1/en active IP Right Grant
- 2000-10-25 MX MXPA02004228A patent/MXPA02004228A/es active IP Right Grant
- 2000-10-25 NZ NZ518566A patent/NZ518566A/en unknown
- 2000-10-25 SI SI200030603T patent/SI1224164T1/xx unknown
- 2000-10-25 HU HU0203270A patent/HUP0203270A3/hu unknown
- 2000-10-25 CN CNB008173680A patent/CN1182107C/zh not_active Expired - Fee Related
- 2000-10-25 DK DK00975954T patent/DK1224164T3/da active
- 2000-10-25 PL PL00356524A patent/PL356524A1/xx unknown
- 2000-10-25 ES ES00975954T patent/ES2233474T3/es not_active Expired - Lifetime
- 2000-10-25 IL IL14936400A patent/IL149364A0/xx unknown
- 2000-10-25 GC GCP2000972 patent/GC0000142A/xx active
- 2000-10-25 KR KR1020027005340A patent/KR20020044578A/ko not_active Application Discontinuation
- 2000-10-25 AR ARP000105622A patent/AR026244A1/es not_active Application Discontinuation
- 2000-10-25 BR BR0015082-7A patent/BR0015082A/pt not_active IP Right Cessation
- 2000-10-26 TW TW089122497A patent/TW561141B/zh active
- 2000-10-26 CO CO00081571A patent/CO5261576A1/es not_active Application Discontinuation
- 2000-10-27 PE PE2000001156A patent/PE20010898A1/es not_active Application Discontinuation
-
2002
- 2002-04-24 ZA ZA200203255A patent/ZA200203255B/en unknown
- 2002-04-25 NO NO20021965A patent/NO20021965L/no unknown
- 2002-12-19 HK HK02109235A patent/HK1049146A1/xx not_active IP Right Cessation
-
2003
- 2003-10-03 US US10/678,679 patent/US20040077727A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0114913A (pt) | Inibidores de metaloproteinase de espiro-pirimidina-2,4,6-triona | |
| BR0001468A (pt) | ácidos dioxiciclopentil hidroxânicos | |
| BR9814147A (pt) | "derivados de ácido carboxìlico e hidroxâmico tendo atividade inibitória de mmp e tnf" | |
| BR9709427A (pt) | Oxa ácidos e compostos relacionados para tratamento de condições da pele | |
| BR0208192A (pt) | Derivados espirotricìclicos e seu uso como inibidores da fosfodiesterase-7. | |
| BR0313371A (pt) | Composto, uso de um composto e método de tratamento de doença | |
| EA200101077A1 (ru) | Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его | |
| BR9811099A (pt) | Inibidores de urocinase | |
| DE60120881D1 (de) | Sulfonamide als matrix-metalloproteinase inhibitoren | |
| BR9916566A (pt) | Complexo de inibidor de ras-farnesiltransferase esulfobutiléter-7-ß-ciclodextrina ou2-hidroxipropil-ß-ciclodextrina e processo | |
| BR0204678A (pt) | Inibidor de nf-kb contendo derivado de ácido benzóico substituìdo como ingrediente ativo | |
| TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
| BR0113389A (pt) | Compostos que inibem a atividade do fator xa | |
| HK1059439A1 (en) | Compounds having activity as inhibitors of cytochrome p450rai | |
| BR0015082A (pt) | Derivado de ácido hidroxâmico como inibidor da formação de cd 23 humano solúvel | |
| BR0213037A (pt) | Derivados de pirimidina | |
| BR0200341A (pt) | Bifenilsulfonamidas proveitosas como inibidores de metaloproteases da matriz | |
| SE9904674D0 (sv) | Novel compounds | |
| WO2001091796A8 (en) | Methods, compounds and compositions for treating gout | |
| BR0113461A (pt) | Compostos ou sais farmaceuticamente aceitáveis, composições farmacêuticas, método de tratamento de doença ou condição mediada por erab, hadh2 ou (beta)-amilóide em mamìferos, métodos de inibição ou modulação da atividade enzimática de erab ou hadh2 e método de tratamento de mal de alzheimer ou demência em mamìferos | |
| ATE360428T1 (de) | Analgetisches arzneimittel | |
| BR0315055A (pt) | Diamidas de ácido pirimidin-4,6-dicarboxìilco para a inibição seletiva de colagenases | |
| EP1123692A3 (fr) | Utilisation de dérivés de polyaminoacides pour traiter la séborrhée et les désordres cutanés associés | |
| WO2002009717A1 (fr) | Remedes contre la dyserection contenant des derives de prostaglandine comme principe actif | |
| BR0008368A (pt) | Derivados fenilalaninol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009. |